RUNX1 and acute lymphoblastic leukemia: To understand the molecular drivers of distinct subtypes of pediatric B-ALL, we incorporated existing genomic and transcriptomic data with newly generated global proteomic and phosphoproteomic profiles for a cohort of patients with either ETV6::RUNX1 B-ALL or Ph-like B-ALL.